139 related articles for article (PubMed ID: 18487080)
1. Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing.
Huang SF; Chen IH; Liao CT; Wang HM; Liou SH; Hsieh LL
Oral Oncol; 2009 Jan; 45(1):16-22. PubMed ID: 18487080
[TBL] [Abstract][Full Text] [Related]
2. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
3. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation.
Tu HF; Chen HW; Kao SY; Lin SC; Liu CJ; Chang KW
Radiother Oncol; 2008 May; 87(2):243-52. PubMed ID: 18423915
[TBL] [Abstract][Full Text] [Related]
4. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese.
Hsieh LL; Wang PF; Chen IH; Liao CT; Wang HM; Chen MC; Chang JT; Cheng AJ
Carcinogenesis; 2001 Sep; 22(9):1497-503. PubMed ID: 11532872
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka.
Chiba I; Muthumala M; Yamazaki Y; Uz Zaman A; Iizuka T; Amemiya A; Shibata T; Kashiwazaki H; Sugiura C; Fukuda H
Int J Cancer; 1998 Sep; 77(6):839-42. PubMed ID: 9714051
[TBL] [Abstract][Full Text] [Related]
7. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan.
Huang SF; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
Head Neck; 2009 Aug; 31(8):1068-77. PubMed ID: 19360742
[TBL] [Abstract][Full Text] [Related]
8. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
[TBL] [Abstract][Full Text] [Related]
9. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Kuo MY; Huang JS; Hsu HC; Chiang CP; Kok SH; Kuo YS; Hong CY
J Oral Pathol Med; 1999 May; 28(5):221-5. PubMed ID: 10226945
[TBL] [Abstract][Full Text] [Related]
10. Novel MDM2 splice variants identified from oral squamous cell carcinoma.
Sam KK; Gan CP; Yee PS; Chong CE; Lim KP; Karen-Ng LP; Chang WS; Nathan S; Rahman ZA; Ismail SM; Cheong SC
Oral Oncol; 2012 Nov; 48(11):1128-35. PubMed ID: 22705356
[TBL] [Abstract][Full Text] [Related]
11. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas.
Hsieh LL; Chien HT; Chen IH; Liao CT; Wang HM; Jung SM; Wang PF; Chang JT; Chen MC; Cheng AJ
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):439-43. PubMed ID: 12750239
[TBL] [Abstract][Full Text] [Related]
12. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
13. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.
Hong Y; Miao X; Zhang X; Ding F; Luo A; Guo Y; Tan W; Liu Z; Lin D
Cancer Res; 2005 Oct; 65(20):9582-7. PubMed ID: 16230424
[TBL] [Abstract][Full Text] [Related]
14. MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer.
Vivenza D; Gasco M; Monteverde M; Lattanzio L; Syed N; Colantonio I; Denaro N; Natoli G; Comino A; Russi E; Merlano M; Crook T; Lo Nigro C
Oral Oncol; 2012 Jul; 48(7):602-7. PubMed ID: 22356895
[TBL] [Abstract][Full Text] [Related]
15. MDM2 SNP309 G allele decreases risk but does not affect onset age or survival of Chinese leukaemia patients.
Phang BH; Linn YC; Li H; Sabapathy K
Eur J Cancer; 2008 Mar; 44(5):760-6. PubMed ID: 18313915
[TBL] [Abstract][Full Text] [Related]
16. p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan.
Wong YK; Liu TY; Chang KW; Lin SC; Chao TW; Li PL; Chang CS
J Oral Pathol Med; 1998 Jul; 27(6):243-8. PubMed ID: 9707275
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
[TBL] [Abstract][Full Text] [Related]
18. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
19. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea.
Thomas S; Brennan J; Martel G; Frazer I; Montesano R; Sidransky D; Hollstein M
Cancer Res; 1994 Jul; 54(13):3588-93. PubMed ID: 8012986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
